Panel discussion
Johnson & Johnson Innovation
| Country: | UK |
| Website: | https://jnjinnovation.com/ |
| Room: | Sydney |
| Date: | 02.05.2022 |
| Time: | 16:30 – 17:15 |
Panel title
Translating innovation into healthcare solutions: How can Switzerland leap ahead?
Panel summary
Switzerland is a global leader in life science innovation, however this innovation doesn’t always translate into healthcare solutions. This panel will discuss how entrepreneurs can gain the right expertise to compete globally for meaningful partnerships and investments.
Speaker information
Moderation
Tahera Kan, VP Head of New Ventures & Transactions, Johnson & Johnson Innovation
Panelists
- Catherine Pickering, CEO, iOncura SA
- Elena Fernandez-Kleinlein, Head JLABS EMEA, Johnson & Johnson Innovation
- Martin Münchbach, Managing Partner, Pureos Bioventures
- Michael Hübner, Director Early Innovation Partnering, Johnson & Johnson Innovation
Company profile
Johnson & Johnson Innovation seeks to positively impact human health through innovation. We do this by helping entrepreneurs realize their dreams of creating healthcare solutions that improve peoples’ lives around the world. We work side-by-side with innovators throughout their journey, providing a robust exchange of ideas and resources to support their success.
Our mission is to create the leading global innovation network to generate transformational healthcare solutions.
